BSE
Your Result on : Company News Details
Glaxosmithkline Pharmaceuticals Ltd Industry :  Pharmaceuticals - Multinational
BSE Code
500660
ISIN Demat
INE159A01016
Book Value (Rs)
132.2958859
NSE Symbol
GLAXO
Divident Yield %
2.69
Market Cap
(Rs In Cr.)
35,926
P/E (TTM)
39.57
EPS (TTM)
53.59
Face Value
(Rs)
10
Back
Glaxosmithkline appoints Vinay Subramanian as Commercial Head – Oncology
21-Apr-26   Hrs IST

Glaxosmithkline Pharmaceuticals announced that Vinay Subramanian, Commercial Head – Oncology would be part of leadership team effective 20 April 2026 based out of Mumbai, and he would be part of senior Management Personnel of the Company effective the said date.

Vinay brings with him over 24 years of experience in the Pharmaceuticals, Life Science. Healthcare Devices, and Medical Technology sectors. Prior to joining GSK. he served as the India Enabling leader - Enterprise & Neighboring Countries at Roche Products India Pvt ltd. where he was responsible for the immunotherapy portfolio and was part of their leadership team.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)